Request For Demo     Request For FreeTrial     Subscribe     Pay Now

Re-Tender For The Procurement Of Anticancer Drugs For Cancer Centers For The Year 2020-21 ...


Contract Award Notice

TRR 4745751
Organization Kerala Medical Services Corporation Limited
Tender No KMSCL/OD/AC/RT/2020/008 dtd.16.09.2020
Funded By Self-Funded
Country India , Southern Asia
Contract Value 25 Million

Work Detail

Re-Tender For The Procurement Of Anticancer Drugs For Cancer Centers For The Year 2020-21 , Abiraterone Tab Ip 250 Mg , Actinomycin D Inj 0 . 5 Mg/3Ml , Amifostine For Inj Usp 500 Mg , Arsenic Trioxide Inj 10 Mg , Azathioprine Tab Ip 50 Mg , Bcg For Immunotherapy Ip 50Mg , Beta-Interferon Inj 30 Mcg , Cabazitaxel Inj 60 Mg , Calcium Leucovorin Tab 15Mg , Carfilzomib Inj 60Mg , Carmustine Inj Ip 100 Mg , Ceritinib Cap 150 Mg , Cetuximab Inj 100Mg , Chlorambucil Tab Ip 2 Mg , Crizotinib Cap 250 Mg , Dacarbazine Inj Ip/Usp 200Mg , Daunorubicin Inj Ip 20Mg , Dexamethasone Tab Ip 8Mg , Dexamethasone Tab Ip 4 Mg , Doxorubicin ( Pegylated Liposomal ) Inj 50 Mg , Doxorubicin Liposomal Inj 20Mg , Enzalutamide Cap 40 Mg , Eribulin Inj 0 . 44 Mg/Ml , Erlotinib Tab Ip 100 Mg , Etoposide Cap Ip 50Mg , Etoposide Inj Ip 100Mg , Exemestane Tab 25 Mg , Fludarabine Phosphate Inj Ip/Usp 50 Mg , Fludarabine Tab 10 Mg , Fosfesterol Tab 120 Mg , Fulvestrant Inj 250 Mg , Hydroxy Urea Cap Ip 500Mg , Ibandronate Tab 50 Mg , Lapatinib Tab Ip 250 Mg , Letrozole Tab Ip/Usp 2 . 5Mg , Lomustine Cap Ip 40 Mg , Megestrol Acetate Tab Ip 40 Mg , Melphalan Tab 5Mg , Melphalan Tab 2 Mg , Methotrexate Inj ( Intrathecal , Preservative Free ) 15Mg , Methotrexate Tab Ip 2 . 5Mg , Methotrexate Tab Ip 15Mg , Mitomycin For Inj Ip 10 Mg , Mitozantrone Infusion Bp/Usp 20 Mg , Octreotide Depot Inj 20Mg , Octreotide Inj 100 Mcg/Ml , Paclitaxel Nanoparticle Inj 100Mg , Plerixafor Inj 24 Mg/1 . 2Ml , Procarbazine Hcl Cap Ip 50 Mg , Sorafenib Tosylate Tab Ip 200Mg , Tegafur +Uracil Cap 100 Mg + 224 Mg , Thioguanine Tab Ip 40G , Topotecan Inj Ip 2 . 5 Mg , Trabectedin Inj 1 Mg , Tretinoin Cap 10 Mg , Vinblastine Sulphate Inj Ip 10Mg , Vincristine Sulphate Inj Ip/Usp 1Mg , Vinorelbine Inj Ip 50 Mg , Zoledronic Acid Inj Ip 4Mg , Cyclosporine Inj Usp 50 Mg , 13-Cis-Retinoic Acid Cap 10Mg , 13-Cis-Retinoic Acid Cap 20Mg , 13-Cis-Retinoic Acid Cap 40Mg , Afatinib Tab 40 Mg , Afatinib Tab 30 Mg , Calcium Leucovorin Inj Ip 15Mg , Calcium Leucovorin Inj Ip 50Mg , Cisplatin Inj Ip 10Mg , Cisplatin Inj Ip 50Mg , Cytarabine Inj Ip/Bp 1 Gm , Cytarabine Inj Ip/Bp 100Mg , Dasatinib Tab 20 Mg , Dasatinib Tab 50 Mg , Decitabine Inj 30Mg , Epirubicin Inj Bp/Usp 10Mg , Epirubicin Inj Bp/Usp 50Mg , Everolimus Tab 10 Mg , Everolimus Tab 5Mg , Flurouracil Inj Ip 500Mg , Flurouracil Inj Ip 250Mg , Imatinib Cap Ip 100Mg , Methotrexate Inj Ip 50Mg , Methotrexate Inj Ip 500 Mg , Methotrexate Inj Ip 1 Gm , Methotrexate Inj Ip 25 Mg , Oxaliplatin Inj Ip 50Mg , Oxaliplatin Inj Ip 100Mg , Pomalidomide Cap 2 Mg , Pomalidomide Cap 4 Mg , Rituximab Inj 600 Mg , Ruxolitinib Tab 10 Mg , Trastuzumab Inj 440 Mg , Trastuzumab Inj 150 Mg , Cyclosporine Cap Ip 25 Mg , Tacrolimus Cap 0 . 25 Mg , Tacrolimus Cap Ip 0 . 5 Mg , 13-Cis-Retinoic Acid Cap 10 Mg , 13-Cis-Retinoic Acid Cap 20 Mg , 13-Cis-Retinoic Acid Cap 40 Mg , Alectinib Cap 150 Mg , Anti-Thymocyte Globulin Inj ( Rabbit ) 25 Mg , Busulphan Inj 60 Mg , Cabazitaxel Inj 60 Mg , Carfilzomib Inj . 60Mg , Ceritinib Cap 150 Mg , Cetuximab Inj 100Mg , Cyclosporine Cap Ip 100 Mg , Cyclosporine Cap Ip 25 Mg , Cyclosporine Cap Ip 50 Mg , Cyclosporine Inj Usp 50 Mg , Dasatinib Tab 20Mg , Dasatinib Tab 50Mg , Dasatinib Tab 70 Mg , Daunorubicin Inj Ip 20Mg , Docetaxel Inj Ip 20Mg , Docetaxel Inj Ip 80Mg , Doxorubicin Inj ( Lyophilised ) Ip 10Mg , Doxorubicin Inj ( Lyophilised ) Ip 50Mg , Enzalutamide Cap 40 Mg , Epirubicin Inj Bp/Usp 10Mg , Epirubicin Inj Bp/Usp 50Mg , Everolimus Tab 10Mg , Everolimus Tab 5 Mg , Fludarabine Phosphate Inj Ip / Usp 50Mg , Idarubicin Inj 10 Mg , Imatinib Cap Ip 100Mg , Imatinib Tab Ip 400 Mg , Ixabepilone Inj 15 Mg , Ixabepilone Inj 45 Mg , Lenvatinib Cap 4 Mg , Lenvatinib Cap 10 Mg , Letrozole Tab Ip/Usp 2 . 5Mg , Lomustine Cap Ip 40Mg , Nimotuzumab Inj 200 Mg , Olaparib Tab 150 Mg , Osimertinib Tab 80 Mg , Oxaliplatin Inj Ip 50Mg , Oxaliplatin Inj Ip 100Mg , Palbociclib Cap 125 Mg , Palbociclib Cap 100 Mg , Panabinostat Tab 20 Mg , Plerixafor Inj 24 Mg/1 . 2Ml , Regorafenib Tab 40 Mg , Tacrolimus Cap Ip 1 Mg , Tacrolimus Cap Ip 0 . 5 Mg , Tacrolimus Tab 0 . 25 Mg , Thiotepa Inj . 15Mg

Key Dates

Contract Date 08 Apr 2021

Contact Information

Company Name
Awarded Bids List
S.No Bid Number Bidder Name Awarded Currency Awarded Value
1 954269 DrReddysLaboratoriesLtd INR 1848000.00
2 957515 Intas Pharmaceuticals Ltd. INR 601378.60
3 959751 Reliance Life Sciences Private Limited INR 17521896.00
4 960101 Merck Specialities Pvt Ltd INR 1770833.00
5 961614 Fresenius Kabi Oncology Limited INR 467460.00
6 962460 NAPROD LIFE SCIENCES PVT LTD INR 5600.00
7 966617 Glenmark Pharmaceuticals Limited INR 2428610.00
Contract Value 25 Million
Contract Date 08 Apr 2021

Complete details of the selected Tender
Organisation Name : Vijaya Bank
Organisation Type : Public Sector Banks Ministry : Ministry of Finance
Tender Ref. No : DIT/DELHIARMB/07052016/1
Tender Title : E-Auction Sale Notice for the properties of M/s Guru Kripa Iron Trading Pvt Ltd, mortgaged to Vijaya Bank and taken possession under the provisions of SARFAESI Act 2002.
Product Category : Land/Building
Sub Category :
Tender Value (INR if not mentioned):
Rs 1,62,00,000/-
EMD :
1620000
Document Cost :
0
Tender Type : Auction
Location : Delhi
First   
Announcement Date :
5-July-2016  
Publication Date on Portal: 5-July-2016 At : 8:03:09 PM  
Last Date of Document Collection :  
8-August-2016 Up To : 5:00 PM  
Last date for  
Submission :
8-August-2016 Up To : 5:00 PM  
Opening Date : 10-August-2016 At : 11:00 AM  
Work Description :
Pre-Qualification :
PreBid Meet Date : --
Tender Document : View Document *
Bid Document : Document Not available
Tech. Document : Document Not available
Sector : Banking, Finance & Insurance
State : Karnataka
 
For further Information Contact:
Name : Santhosh Aili
E-Mail : cbsprog11@vijayabank.co.in
Phone Office : 08025584066
Fax : 08025582747
Address :
City : Bangalore

  download Adobe® Reader®
Adobe® and Get Adobe® Reader® logo are trademarks or registered trademarks of Adobe Systems Inc. in the US and/or other countries.

View Notice Now...

Login with your Social Account for Instant Access to this notice


Tell us about your Product / Services,
We will Find Tenders for you